Stock Scorecard
Stock Summary for Ensysce Biosciences Inc (ENSC) - $0.54 as of 4/22/2024 11:37:08 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ENSC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ENSC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ENSC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for ENSC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for ENSC
Financial Details for ENSC
Company Overview |
|
|---|---|
| Ticker | ENSC |
| Company Name | Ensysce Biosciences Inc |
| Country | USA |
| Description | Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California. |
| Sector Name | REAL ESTATE & CONSTRUCTION |
| Industry Name | BLANK CHECKS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/13/2024 |
Stock Price History |
|
| Last Day Price | 0.54 |
| Last Day Price Updated | 4/22/2024 11:37:08 PM EST |
| Last Day Volume | 53,698 |
| Average Daily Volume | 114,137 |
| 52-Week High | 4.23 |
| 52-Week Low | 0.53 |
| Last Price to 52 Week Low | 1.89% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 85.72 |
| Sector PE | 63.45 |
| 5-Year Average PE | 6.19 |
| Free Cash Flow Ratio | 3.60 |
| Industry Free Cash Flow Ratio | 277.31 |
| Sector Free Cash Flow Ratio | 173.60 |
| Current Ratio Most Recent Quarter | 0.69 |
| Total Cash Per Share | 0.15 |
| Book Value Per Share Most Recent Quarter | -0.10 |
| Price to Book Ratio | 1.68 |
| Industry Price to Book Ratio | 3.05 |
| Sector Price to Book Ratio | 3.51 |
| Price to Sales Ratio Twelve Trailing Months | 2.45 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.54 |
| Sector Price to Sales Ratio Twelve Trailing Months | 3.44 |
Share Statistics |
|
| Total Shares Outstanding | 7,329,200 |
| Market Capitalization | 3,957,768 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 56.09% |
| Reported EPS 12 Trailing Months | -4.69 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -5.30 |
| Net Income Twelve Trailing Months | -10,613,074 |
| Net Income Past Year | -10,613,074 |
| Net Income Prior Year | -24,172,292 |
| Quarterly Revenue Growth YOY | -64.10% |
| 5-Year Revenue Growth | 46.92% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,123,604 |
| Total Cash Past Year | 1,123,604 |
| Total Cash Prior Year | 3,147,702 |
| Net Cash Position Most Recent Quarter | 268,907 |
| Net Cash Position Past Year | 268,907 |
| Long Term Debt Past Year | 854,697 |
| Long Term Debt Prior Year | 4,717,104 |
| Total Debt Most Recent Quarter | 854,697 |
| Equity to Debt Ratio Past Year | -0.61 |
| Equity to Debt Ratio Most Recent Quarter | -0.61 |
| Total Stockholder Equity Past Year | -322,858 |
| Total Stockholder Equity Prior Year | -3,714,444 |
| Total Stockholder Equity Most Recent Quarter | -322,858 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.06 |
| MACD Signal | -0.05 |
| 20-Day Bollinger Lower Band | 0.43 |
| 20-Day Bollinger Middle Band | 0.98 |
| 20-Day Bollinger Upper Band | 1.52 |
| Beta | 0.76 |
| RSI | 24.47 |
| 50-Day SMA | 1.46 |
| 200-Day SMA | 952.63 |
System |
|
| Modified | 4/22/2024 11:37:09 PM EST |